Skip to main content

Rabbit Polyclonal ACL6A antibody. Suitable for WB, IHC-P, ICC/IF and reacts with Human samples. Immunogen corresponding to Synthetic Peptide within Human ACTL6A aa 200-250.

Be the first to review this product! Submit a review

Images

Western blot - Anti-ACTL6A antibody (AB189315), expandable thumbnail
  • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ACTL6A antibody (AB189315), expandable thumbnail
  • Immunocytochemistry/ Immunofluorescence - Anti-ACTL6A antibody (AB189315), expandable thumbnail

Key facts

Isotype
IgG
Host species
Rabbit
Storage buffer

pH: 7.4
Preservative: 0.02% Sodium azide
Constituents: 50% Glycerol (glycerin, glycerine), 49% PBS, 0.88% Sodium chloride

Form
Liquid
Clonality
Polyclonal

Immunogen

  • Synthetic Peptide within Human ACTL6A aa 200-250. The exact immunogen used to generate this antibody is proprietary information. Database link O96019

Reactivity data

Select an application
Product promiseTestedExpectedPredictedNot recommended
WBIHC-PICC/IF
Human
Tested
Tested
Tested
Cynomolgus monkey
Predicted
Predicted
Predicted

Tested
Tested

Species
Human
Dilution info
1/500.00000 - 1/1000.00000
Notes

-

Predicted
Predicted

Species
Cynomolgus monkey
Dilution info
-
Notes

-

Tested
Tested

Species
Human
Dilution info
20 µg/mL
Notes

-

Predicted
Predicted

Species
Cynomolgus monkey
Dilution info
-
Notes

-

Tested
Tested

Species
Human
Dilution info
1/100.00000 - 1/500.00000
Notes

-

Predicted
Predicted

Species
Cynomolgus monkey
Dilution info
-
Notes

-

Associated Products

Select an associated product type

2 products for Alternative Product

Target data

Function

Involved in transcriptional activation and repression of select genes by chromatin remodeling (alteration of DNA-nucleosome topology). Component of SWI/SNF chromatin remodeling complexes that carry out key enzymatic activities, changing chromatin structure by altering DNA-histone contacts within a nucleosome in an ATP-dependent manner. Required for maximal ATPase activity of SMARCA4/BRG1/BAF190A and for association of the SMARCA4/BRG1/BAF190A containing remodeling complex BAF with chromatin/nuclear matrix. Belongs to the neural progenitors-specific chromatin remodeling complex (npBAF complex) and is required for the proliferation of neural progenitors. During neural development a switch from a stem/progenitor to a postmitotic chromatin remodeling mechanism occurs as neurons exit the cell cycle and become committed to their adult state. The transition from proliferating neural stem/progenitor cells to postmitotic neurons requires a switch in subunit composition of the npBAF and nBAF complexes. As neural progenitors exit mitosis and differentiate into neurons, npBAF complexes which contain ACTL6A/BAF53A and PHF10/BAF45A, are exchanged for homologous alternative ACTL6B/BAF53B and DPF1/BAF45B or DPF3/BAF45C subunits in neuron-specific complexes (nBAF). The npBAF complex is essential for the self-renewal/proliferative capacity of the multipotent neural stem cells. The nBAF complex along with CREST plays a role regulating the activity of genes essential for dendrite growth (By similarity). Component of the NuA4 histone acetyltransferase (HAT) complex which is involved in transcriptional activation of select genes principally by acetylation of nucleosomal histones H4 and H2A. This modification may both alter nucleosome - DNA interactions and promote interaction of the modified histones with other proteins which positively regulate transcription. This complex may be required for the activation of transcriptional programs associated with oncogene and proto-oncogene mediated growth induction, tumor suppressor mediated growth arrest and replicative senescence, apoptosis, and DNA repair. NuA4 may also play a direct role in DNA repair when recruited to sites of DNA damage. Putative core component of the chromatin remodeling INO80 complex which is involved in transcriptional regulation, DNA replication and probably DNA repair.

Alternative names

Recommended products

Rabbit Polyclonal ACL6A antibody. Suitable for WB, IHC-P, ICC/IF and reacts with Human samples. Immunogen corresponding to Synthetic Peptide within Human ACTL6A aa 200-250.

Key facts

Isotype
IgG
Form
Liquid
Clonality
Polyclonal
Immunogen
  • Synthetic Peptide within Human ACTL6A aa 200-250. The exact immunogen used to generate this antibody is proprietary information. Database link O96019
Purification technique
Affinity purification Immunogen
Concentration
Loading...

Storage

Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary info

This supplementary information is collated from multiple sources and compiled automatically.
Activity summary

ACTL6A also known as BAF53A or Arp4 is a member of the actin-related protein family with a molecular mass of approximately 53 kDa. This protein plays an important role in chromatin remodeling facilitating transcriptional regulation by altering nucleosome positioning. ACTL6A shows expression in various tissues with high levels found in neurons and certain cancer cell types. Its function depends on local cellular context which influences its involvement in specific gene expression profiles.

Biological function summary

ACTL6A supports transcriptional regulation by integrating into the SWI/SNF chromatin-remodeling complex. This complex which includes other key proteins coordinates to reposition nucleosomes aiding transcription factors in accessing target DNA sequences. ACTL6A contributes to regulation of gene expression patterns that underline cell identity and differentiation reflecting its critical role in neuronal and cancer cell biology.

Pathways

The SWI/SNF complex which includes ACTL6A integrates into pathways that control cell proliferation and differentiation. Specifically the Wnt signaling pathway uses ACTL6A to regulate gene expression necessary for proper cell function. Proteins like BRG1 and BRM serve as partners in this process helping to execute transcriptional activation. By participating in these pathways ACTL6A emphasizes its role in conserving cellular homeostasis.

Associated diseases and disorders

ACTL6A exhibits associations with oncogenesis and neural disorders. Researchers observed its link to the development of glioblastoma where it influences tumor progression through interactions with other SWI/SNF members like SMARCA4. Additionally abnormalities in ACTL6A function relate to neurodevelopmental disorders emphasizing its importance in neuronal growth and differentiation. Its connection to these diseases highlights the potential of ACTL6A as a target for therapeutic interventions.

Product promise

We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.

In the unlikely event of one of our products not working as expected, you are covered by our product promise.

Full details and terms and conditions can be found here:
Terms & Conditions.

3 product images

  • Western blot - Anti-ACTL6A antibody (ab189315), expandable thumbnail

    Western blot - Anti-ACTL6A antibody (ab189315)

    All lanes: Western blot - Anti-ACTL6A antibody (ab189315) at 1/500 dilution

    Lane 1: Jurkat cell extracts

    Lane 2: COLO205 cell extracts

    Lane 3: Cell extracts treated with synthesized peptide.

    Predicted band size: 47 kDa

  • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ACTL6A antibody (ab189315), expandable thumbnail

    Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ACTL6A antibody (ab189315)

    Immunohistochemical analysis of formalin-fixed, paraffin-embedded Human skin tissue, labeling ACTL6A with ab189315 at 20 μg/ml.

  • Immunocytochemistry/ Immunofluorescence - Anti-ACTL6A antibody (ab189315), expandable thumbnail

    Immunocytochemistry/ Immunofluorescence - Anti-ACTL6A antibody (ab189315)

    Immunofluorescent analysis of HUVEC cells labeling ACTL6A with ab189315 at 1/100 dilution. The picture on the right is treated with the synthesized peptide.

Downloads

Product protocols

For this product, it's our understanding that no specific protocols are required. You can:

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com